Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients

Chiara Massa; Thomas Karn; Karsten Weber; Andreas Schneeweiss; Claus Hanusch; Jens Uwe Blohmer; Dirk-Michael Zahm; Christian Jackisch; Marion van Mackelenbergh; Jörg Thomalla; Frederik Marmé; Jens Huober; Volkmar Müller; Christian Schem; Anja Müller; Elmar Stickeler; Katharina Biehl; Peter A. Fasching; Michael Untch; Sibylle Loibl; Carsten Denkert; Barbara Seliger

doi:10.1002/ctm2.1617

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (4) : e1617 DOI: 10.1002/ctm2.1617

LETTER TO THE JOURNAL

Baseline CD4⁺ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients

Author information +

¹. Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany

². Institute for Translational Immunology, Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany

³. Department of Obstetrics and Gynecology, Goethe University, Frankfurt, Germany

⁴. German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany

⁵. Nationales Centrum für Tumorerkrankungen, Universitätsklinikum und Deutsches Krebsforschungszentrum, Heidelberg, Germany

⁶. Rotkreuzklinikum München, München, Germany

⁷. Gynäkologie mit Brustzentrum der Charite CCM, Charité-Universitätsmedizin Berlin, Berlin, Germany

⁸. SRH Wald-Klinikum Gera, Gera, Germany

⁹. Department of Obstetrics and Gynecology, Sana Klinikum Offenbach, Offenbach, Germany

¹⁰. Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Kiel, Germany

¹¹. Praxis für Hämatologie und Onkologie, Koblenz, Germany

¹². Universitätsfrauenklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Heidelberg, Germany

¹³. Breast Cancer, Cantonal Hospital St.Gallen, St. Gallen, Switzerland

¹⁴. Department of Obstetrics and Gynecology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

¹⁵. Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany

¹⁶. Klinik für Gynäkologie und Geburtsmedizin, Uniklinik RWTH Aachen, Aachen, Germany

¹⁷. Department of Obstetrics and Gynecology, Universitätsklinikum Erlangen, Erlangen, Germany

¹⁸. Department of Obstetrics and Gynecology, HELIOS Klinikum Berlin Buch, Berlin, Germany

¹⁹. Institute of Pathology, Philipps-University Marburg and University Hospital Marburg (UKGM), Marburg, Germany

barbara.seliger@uk-halle.de

Show less

History +

PDF

Cite this article

Download citation ▾

Chiara Massa,Thomas Karn,Karsten Weber,Andreas Schneeweiss,Claus Hanusch,Jens Uwe Blohmer,Dirk-Michael Zahm,Christian Jackisch,Marion van Mackelenbergh,Jörg Thomalla,Frederik Marmé,Jens Huober,Volkmar Müller,Christian Schem,Anja Müller,Elmar Stickeler,Katharina Biehl,Peter A. Fasching,Michael Untch,Sibylle Loibl,Carsten Denkert,Barbara Seliger. Baseline CD4⁺ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. Clinical and Translational Medicine, 2024, 14(4): e1617 DOI:10.1002/ctm2.1617

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.